STRIDE - STimulating Immune Response In aDvanced brEast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: BIOLOGICAL: Tecemotide (L-BLP25) and Hormonal Treatment|BIOLOGICAL: Placebo of tecemotide (L-BLP25) and Hormonal Treatment|DRUG: cyclophosphamide|DRUG: sodium chloride (NaCl)
Sponsor: EMD Serono